Ibrukem 140 mg Capsule
101,99$
79,55$
Ibrukem 140 mg capsules are a targeted treatment option for adults battling specific types of blood cancers, including mantle cell lymphoma (MCL), chronic lymphocytic leukaemia (CLL), and Waldenström's macroglobulinaemia (WM). This innovative medication functions by effectively inhibiting the activity of protein kinases, which play a crucial role in cancer cell growth and survival. By disrupting these pathways, Ibrukem helps to slow down or stop the progression of these malignancies. Patients should be aware of potential side effects and the importance of regular monitoring during treatment, as this medication may not be suitable for everyone. It is essential to consult with a healthcare provider before starting Ibrukem to ensure it aligns with your treatment plan and health profile. With its targeted approach, Ibrukem 140 mg capsules represent a significant advancement in the management of certain hematological cancers, offering hope for improved outcomes. If you're seeking effective therapy for blood cancers, Ibrukem may be a vital component of your treatment journey.
Quantité
Active Pharmaceutical Ingredient
Uses
• Ibrukem 140 mg capsule is primarily used in the treatment of chronic lymphocytic leukemia (CLL). This condition is characterized by the accumulation of abnormal lymphocytes in the blood and bone marrow. By targeting specific pathways involved in the growth of these cells, Ibrukem helps manage the symptoms and progression of the disease. Patients often experience improved blood counts and overall health with this treatment.
• Another important application of Ibrukem 140 mg capsule is in the management of mantle cell leukemia. This aggressive form of cancer affects B-cells and can lead to rapid disease progression. Ibrukem works by inhibiting certain proteins that promote cancer cell survival, thereby slowing down the disease. As a result, patients may have a better quality of life and extended time without disease progression.
• Ibrukem 140 mg capsule is also effective for treating Waldenström's macroglobulinemia, a type of lymphoma that results in high levels of monoclonal immunoglobulin. The medicine helps reduce the abnormal protein levels in the blood, which can alleviate symptoms associated with this condition. By addressing the underlying mechanisms of the disease, Ibrukem supports patients in managing their symptoms more effectively. This can lead to improved overall wellbeing and functionality in daily activities.
Benefits
Ibrukem 140 mg Capsule helps in treating blood cancer in patients who were not able to recover from previous medications. It helps to prevent the cancer cells to grow and multiply.
Side Effects
Like all medicines, this medicine can cause side effects, although not everybody gets them. The following side effects may happen with this medicine:
Most Common Side Effects
• Swollen feet and ankle
• Body pain Blurred Vision
• Vomiting
• Nausea
• Pneumonia
• Bloody Urine
• Constipation
• Breathlessness
• Bruises and Rashes
• Tiredness
• Numbness and Weakness
• Mouth Sores
Common Side Effects
• Low Count of Blood Cells
• High Blood Pressure
• Tumor Lysis Syndrome
• Allergic Reactions
• Infections
• Heart Problems
How To Use
Ibrukem 140 mg Capsule can be taken without or with food, as advised by your doctor. You must follow every guideline of your doctor strictly to get the best results.
Safety Advice
Not Found